RxDoctor Payments DataLook up a doctor →

Scott Parry, DO

Internal Medicine · Atlanta, GANPI 1306860101

Payments from drug & device makers

$162,198in general payments, 2019–2025

Across 1,314 payments — averaging $123.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$120K
  • Gilead$27K
  • AbbVie$2K
  • Merck$1K
  • Novo Nordisk$1K
  • Johnson & Johnson$1K
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company228$120,483
Gilead197$26,789
AbbVie(2 entities)169$2,084
Merck77$1,492
Novo Nordisk70$1,103
Johnson & Johnson(2 entities)81$1,030
Antares Pharma, Inc.41$734
Pfizer41$623
EMD Serono, Inc.29$552
AstraZeneca29$442
Theratechnologies Inc.22$441
Lilly USA, LLC20$355
Takeda Pharmaceuticals U.S.A., Inc.17$348
Amgen22$342
Otsuka America Pharmaceutical, Inc.14$309
Napo Pharmaceuticals Inc11$298
Noven Therapeutics, LLC18$297
Axsome Therapeutics, Inc.11$284
Boehringer Ingelheim16$264
Tris Pharma Inc12$258
Lundbeck LLC12$237
Teva Pharmaceuticals USA, Inc.11$234
Idorsia Pharmaceuticals US Inc11$228
Biohaven Pharmaceuticals, Inc.8$226
Amarin Pharma, Inc.11$197
Abbott10$180
Corium, LLC7$158
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$151
Biohaven Pharmaceutical Holding Company Ltd.7$149
Jazz Pharmaceuticals Inc.6$139
Janssen Products, LP2$129
Sanofi-aventis U.S. LLC6$103
GSK5$103
Kowa Pharmaceuticals America, Inc.8$101
Endo Pharmaceuticals Inc.6$99
Vanda Pharmaceuticals Inc.3$87
Bausch Health US, LLC5$85
Exact Sciences4$78
Halozyme Inc4$70
Currax Pharmaceuticals LLC4$67
Novartis3$61
Shire North American Group Inc4$57
Tolmar, Inc.3$55
Supernus Pharmaceuticals, Inc.3$53
Esperion Therapeutics, Inc.3$51
Aytu Biopharma, Inc.3$50
Nalpropion Pharmaceuticals LLC3$48
Azurity Pharmaceuticals, Inc.2$44
Ironshore Pharmaceuticals Inc.2$39
Clarus Therapeutics Inc.4$38
Metuchen Pharmaceuticals2$35
OWP Pharmaceuticals, Inc.2$35
Neos Therapeutics, LP2$34
Eisai Inc.2$32
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$28
Bayer1$24
Acerus Pharmaceuticals Corporation2$24
Astellas Pharma US Inc1$20
Phathom Pharmaceuticals, Inc.1$19
Janssen Scientific Affairs, LLC1$17

How this compares

$162,198 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Medicare billing

Part B allowed, 2024
$31,090
Medicare patients
105
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →